-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$0.01-99.63% Downside
Guardion Health Sciences, Inc. Frequently Asked Questions
-
What analysts cover Guardion Health Sciences, Inc.?
Guardion Health Sciences, Inc. has been rated by research analysts at Hovde Group in the past 90 days.